Bio-Rad Labs Files 8-K on Financial Results and Operations
Ticker: BIO-B · Form: 8-K · Filed: Feb 15, 2024 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | 8-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results, 8-K, disclosure
TL;DR
**Bio-Rad just filed an 8-K for financial results, but the actual numbers aren't in this snippet!**
AI Summary
BIO-RAD LABORATORIES, INC. filed an 8-K on February 15, 2024, reporting on its Results of Operations and Financial Condition, along with Financial Statements and Exhibits. This filing indicates the company is disclosing its financial performance, though the specific details, dollar amounts, and full financial statements are not included in the provided excerpt of the document. The event date reported was also February 15, 2024.
Why It Matters
This 8-K filing signals that Bio-Rad Laboratories is publicly disclosing its recent financial performance, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure of financial results, and without the actual content, it presents no inherent risk.
Key Players & Entities
- BIO-RAD LABORATORIES, INC. (company) — Registrant
- Delaware (company) — State of incorporation
- 1000 Alfred Nobel Dr. Hercules, California 94547 (company) — Principal executive offices
- 0000012208 (company) — Central Index Key (CIK)
FAQ
What is the name of the registrant company for this 8-K filing?
The registrant company is BIO-RAD LABORATORIES, INC.
What was the date of the earliest event reported in this 8-K?
The date of the earliest event reported was February 15, 2024.
What items of information are included in this 8-K filing?
The 8-K includes 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per the ITEM INFORMATION.
What is the Commission File Number for BIO-RAD LABORATORIES, INC.?
The Commission File Number is 1-7928.
Where are the principal executive offices of BIO-RAD LABORATORIES, INC. located?
The principal executive offices are located at 1000 Alfred Nobel Dr., Hercules, California 94547.
Filing Stats: 533 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-15 16:24:31
Key Financial Figures
- $0.0001 — stered Class A Common Stock, Par Value $0.0001 per share BIO New York Stock Exchange
Filing Documents
- bio-20240215.htm (8-K) — 33KB
- bio-8k2152024xex991.htm (EX-99.1) — 461KB
- 0000012208-24-000008.txt ( ) — 690KB
- bio-20240215.xsd (EX-101.SCH) — 3KB
- bio-20240215_def.xml (EX-101.DEF) — 15KB
- bio-20240215_lab.xml (EX-101.LAB) — 30KB
- bio-20240215_pre.xml (EX-101.PRE) — 16KB
- bio-20240215_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
ITEM 2.02 Results of Operations and Financial Condition On February 15, 2024, Bio-Rad Laboratories, Inc. announced its financial results for the quarter ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
ITEM 9.01 Financial Statements and Exhibits Exhibit Number Description 99.1 Press release of Bio-Rad Laboratories, Inc. dated February 15, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-RAD LABORATORIES, INC. Date: February 15, 2024 By: /s/ Norman Schwartz Norman Schwartz President and Chief Executive Officer